SOPHARMA AD - Notification for sale of treasury shares

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Current report_3_treasury_shares_espi.pdfNotification for sale of treasury shares
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 3 / 2026

Date of issue: 2026-01-08

Short name of the issuer

SOPHARMA AD

Subject

Notification for sale of treasury shares

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on January 07, 2026 the Company sold 13 710 (thirteen thousand seven hundred and ten) treasury shares representing 0.003% of the share capital of the Company, at a total value of EUR 22 607.40 on the Bulgarian Stock Exchange, the average price per share was EUR 1.65.
The total number of treasury shares after this transaction is 13 515 131 representing 2.51% of the share capital of the Company.

Annexes

File Description

Current report_3_treasury_shares_espi.pdfCurrent report_3_treasury_shares_espi.pdf Notification for sale of treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2026-01-08 Ognian Ivanov Donev Executive Director